| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 31-Dec-08 | | Total Revenue | 28,985 | 27,755 | 28,922 | 39,260 | | Cost of Revenue | 19,828 | 20,610 | 21,023 | 27,650 | | | Gross Profit | 9,157 | 7,145 | 7,899 | 11,610 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 8,997 | 9,072 | 9,863 | 10,081 | | Non Recurring |
-
|
-
|
-
| 11,247 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 160 | (1,927) | (1,964) | (9,718) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (747) | (1,927) | (1,964) | (9,718) | | Interest Expense | (600) | 323 | 277 | 245 | | Income Before Tax | (147) | (2,250) | (2,241) | (9,963) | | Income Tax Expense | (228) | (146) | (834) | 911 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 81 | (2,104) | (1,407) | (10,874) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 81 | (2,104) | (1,407) | (10,874) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $81 | ($2,104) | ($1,407) | ($10,874) |
|
0.20% Nasdaq 
Income Statement
